Israel’s DreaMed Diabetes said on Monday the U.S. Food and Drug Administration has approved for marketing its Advisor Pro software to help manage diabetes treatment.
Read more on Reuters here.
![[DreaMed in Reuters] Israel’s DreaMed gets FDA ok for diabetes management software](https://blog.ourcrowd.com/wp-content/uploads/2017/11/reuters-NEW.jpg)
A better way to invest in startups.
Follow Us
A better way to invest in startups.
Israel’s DreaMed Diabetes said on Monday the U.S. Food and Drug Administration has approved for marketing its Advisor Pro software to help manage diabetes treatment.
Read more on Reuters here.